Invest in Vegalab

Scalable Biotech Platform in Agrobiologicals, Biosecurity, Water, and Cosmetics

A Swiss biotech platform scaling natural agrobiologicals, animal biosecurity, and water purification globally—through direct investment and country franchise/JV models.

Vegalab SA (headquartered in Zug, Switzerland) develops and manufactures natural product solutions supported by proprietary formulation technologies such as micronization and nano-encapsulation designed to improve stability, penetration, and performance while staying cost competitive.

We have demonstrated commercial traction in the past, with historical revenues publicly audited in prior operations, and gross margin ranges cited at ~40–80% depending on product/channel mix.

What we offer investors: scalable expansion into the US, Canada, and high-potential international markets via direct investment into operations and country-level franchise/JV with exclusive territory rights and clear paths to liquidity—including strategic M&A and potential public-market outcomes.

Vegalab offers

- Proprietary tech that makes natural products perform

Our formulation approach leverages micronization and nano-encapsulation to create strong efficacy from plant-derived actives and other inputs.

- Capital-efficient scaling model

Vegalab’s expansion is built to scale through distribution partners and country operating companies, so capital goes toward inventory, registrations, field trials, and sales execution rather than rebuilding core technology from scratch.

- Proof points and third-party validation

Vegalab products have been reviewed and tested with input from distributors/customers and independent institutions including universities and labs.

 This page is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. Any offering, if made, will be conducted only through definitive documentation and in compliance with applicable laws and regulations.